Compounds useful for increasing neurogenesis in neural tissue
The invention described herein is directed to the use of acetyl L-carnitine, or propionyl L-carnitine, or a salt thereof, for preparing a medicament for increasing neurogenesis in neural tissue; in which said increased neurogenesis is useful for preventing central nervous system disorders due to ageing or genetic predisposition.
1. A method for increasing neurogenesis in a patient in need thereof, said method consisting of administering to said patient in need a dose of an active agent, said active agent consisting of acetyl L-carnitine or a salt thereof, wherein said dose corresponds to 1.00 g/day to 2.00 g/day administered in a single or multiple doses, and
increasing said neurogenesis in said patient.
2. The method of claim 1 , wherein the salt of acetyl L-carnitine is selected from the group consisting of: chloride, bromide, orotate, aspartate, acid aspartate, acid citrate, magnesium citrate, phosphate, acid phosphate, fumarate and acid fumarate, magnesium fumarate, lactate, maleate and acid maleate, oxalate, acid oxalate, pamoate, acid pamoate, sulphate, acid sulphate, glucose phosphate, tartrate and acid tartrate, glycerophosphate, mucate, magnesium tartrate, 2-amino-ethanesulphonate, magnesium 2-amino-ethanesulphonate, methanesulphonate, choline tartrate, trichloroacetate, and trifluoroacetate.
3. The method of claim 1 , wherein the acetyl L-carnitine is administered in a dose of 1.5 g/day, in a single or multiple doses.
4. The method of claim 1 , wherein the acetyl L-carnitine is administered by oral, subcutaneous, transdermal, intraperitoneal, intramuscular, in vein, intracerebroventricular, intraparenchymal, intrathecal, intracranial, buccal, mucosal, nasal, pulmonary, rectal administration or by a liposome delivery system.